Reasons for scheduling delegates' final decisions, May 2012
Scheduling medicines and poisons
30 May 2012
Reasons for scheduling Delegate's final decisions, May 2012 - Delegate-only
Delegates' final decisions and reasons on scheduling matters relate to applications considered as delegate-only decisions. These applications were not referred to an expert advisory committee.
How to access a pdf or Word document
- Reasons for scheduling Delegate's final decisions, May 2012 - Delegate-only (pdf,139kb)
- Reasons for scheduling Delegate's final decisions, May 2012 - Delegate-only (Microsoft Word,159kb)
Contents
- Glossary
- Final decisions on matters not referred to an advisory committee
- Chemicals
- 1.1 Sedaxane
- 1.2 Bistrifluron
- Medicines
- 2.1 Ethyl alcohol
- 2.2 Axitinib
- 2.3 Cobicistat
- 2.4 Elvitegravir
- Editorials and errata
- 3.1 Poisons Standard Reference Review
- Chemicals
Reasons for scheduling Delegate's final decisions, May 2012 - ACCS/ACMS consideration
Delegates' final decisions on scheduling matters initially referred to the October 2011 meeting of the ACMS#4, and the February 2012 meeting of the ACCS#4, ACMS#5.
How to access a pdf or Word document
*Large file warning: Attempting to open large pdf files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.
- Reasons for scheduling Delegate's final decisions, May 2012 - ACCS/ACMS consideration (pdf,802kb)
- Reasons for scheduling Delegate's final decisions, May 2012 - ACCS/ACMS consideration (Microsoft Word,163kb)
Contents
- Glossary
- Final decisions on matters referred to an advisory committee
- 1. Matters initially referred to ACCS#4 - February 2012
- 1.1 Cyflufenamid
- 1.2 Diethylphthalate and Dimethylphthalate
- 1.3 Flonicamid
- 1.4 Formaldehyde and Paraformaldehyde
- 1.5 Zinc borate, Boric acid and Borax
- 2. Matters initially referred to ACMS#5 - February 2012
- 2.1 Proposed changes to Part 4 of the SUSMP (The Schedules)
- 2.1.1 Adrenaline
- 2.1.2 Ciclopirox
- 2.1.3 Ibuprofen
- 2.1.4 Loperamide
- 2.1.5 Loratadine
- 2.1.6 Pantoprazole
- 2.1.7 Paracetamol
- 2.2 Proposed changes to Part 5 of the SUSMP (The Appendices)
- 2.2.1 Boceprevir
- 2.2.2 Teleprevir
- 2.1 Proposed changes to Part 4 of the SUSMP (The Schedules)
- 3. Matters initially referred to ACMS#4 - October 2011
- 3.1 Proposed changes to Part 2 of the SUSMP
- 3.1.1 Schedule 8 labelling requirements
- 3.1 Proposed changes to Part 2 of the SUSMP
Content last updated: Wednesday, 30 May 2012
Content last reviewed: Wednesday, 30 May 2012
Web page last updated: Friday, 21 December 2012
URL: http://www.tga.gov.au/industry/scheduling-decisions-1205-final.htm